[{"Assets_0_Q3_USD":6718662000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":180485000.0,"NetIncomeLossConverted_1_Q3_USD":269326000.0,"NetIncomeLossConverted_3_Q3_USD":1194143000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":30234000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":30292000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":29863000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29822000.0,"StockholdersEquity_0_Q3_USD":4900481000.0,"EarningsPerShareBasic_1_Q3_USD":9.02,"EarningsPerShareBasic_3_Q3_USD":40.04,"EarningsPerShareDiluted_1_Q3_USD":8.89,"EarningsPerShareDiluted_3_Q3_USD":39.5,"RevenuesConverted_1_Q3_USD":545138000.0,"RevenuesConverted_3_Q3_USD":1672568000.0,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20181105"}]